UB12:LSE:LSE- (GBX)

ETF | Others |

Last Closing

USD 7320

Change

-21.50 (-0.29)%

Market Cap

USD 0.30B

Volume

580.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-0.16 (-0.06%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

+0.91 (+1.35%)

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

+4.75 (+2.43%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+1.19 (+0.96%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.18 (+1.30%)

USD 608.02B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.23 (+1.32%)

USD 608.02B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+20.50 (+1.02%)

USD 321.87B
0QZK:LSE Coca-Cola Co.

-0.15 (-0.23%)

USD 266.08B
0QZO:LSE 0QZO

-0.80 (-0.78%)

USD 258.54B

ETFs Containing UB12:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.78% 63% D 63% D
Dividend Return 0.00% 2% F 4% F
Total Return 6.78% 62% D 63% D
Trailing 12 Months  
Capital Gain 10.91% 55% F 59% D-
Dividend Return 0.00% 9% A- 6% D-
Total Return 10.91% 54% F 58% F
Trailing 5 Years  
Capital Gain 26.52% 51% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.52% 48% F 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 5.58% 54% F 60% D-
Dividend Return 5.58% 53% F 59% D-
Total Return 0.00% 3% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 10.34% 67% D+ 80% B-
Risk Adjusted Return 53.93% 66% D+ 78% C+
Market Capitalization 0.30B 61% D- 46% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.